Eton Pharmaceuticals, Inc. (ETON) stock
ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$61.99−1.66 (-2.61%)
Close on Nov 18, 2026Market cap $1.77BP/E 158.9Yield –
Eton Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Eton Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $105.60M, up 81.5% year over year. For fiscal 2025 it was $79.95M, up 104.9% from the year before. The highest annual figure on record is $79.95M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $79.95M | +104.9% |
| FY2024 | Dec 31, 2024 | $39.01M | +23.3% |
| FY2023 | Dec 31, 2023 | $31.64M | +48.9% |
| FY2022 | Dec 31, 2022 | $21.25M | -2.7% |
| FY2021 | Dec 31, 2021 | $21.83M | +55879.5% |
| FY2020 | Dec 31, 2020 | $39.00K | -95.9% |
| FY2019 | Dec 31, 2019 | $959.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $37.59M | +98.6% |
| Q1 FY2026 | Mar 31, 2026 | $24.27M | +40.4% |
| Q4 FY2025 | Dec 31, 2025 | $21.28M | +82.7% |
| Q3 FY2025 | Sep 30, 2025 | $22.46M | +117.5% |
| Q2 FY2025 | Jun 30, 2025 | $18.93M | +108.6% |
| Q1 FY2025 | Mar 31, 2025 | $17.28M | +116.9% |
| Q4 FY2024 | Dec 31, 2024 | $11.65M | +59.3% |
| Q3 FY2024 | Sep 30, 2024 | $10.32M | +46.9% |
| Q2 FY2024 | Jun 30, 2024 | $9.07M | -24.4% |
| Q1 FY2024 | Mar 31, 2024 | $7.97M | +50.2% |
| Q4 FY2023 | Dec 31, 2023 | $7.31M | -13.9% |
| Q3 FY2023 | Sep 30, 2023 | $7.03M | +118.3% |
| Q2 FY2023 | Jun 30, 2023 | $12.00M | +63.0% |
| Q1 FY2023 | Mar 31, 2023 | $5.30M | +143.8% |
| Q4 FY2022 | Dec 31, 2022 | $8.50M | +39.5% |
| Q3 FY2022 | Sep 30, 2022 | $3.22M | +315.4% |
| Q2 FY2022 | Jun 30, 2022 | $7.36M | +139.9% |
| Q1 FY2022 | Mar 31, 2022 | $2.18M | -81.7% |
| Q4 FY2021 | Dec 31, 2021 | $6.09M | +7422.2% |
| Q3 FY2021 | Sep 30, 2021 | $775.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $3.07M | +15235.0% |
| Q1 FY2021 | Mar 31, 2021 | $11.90M | +11917.2% |
| Q4 FY2020 | Dec 31, 2020 | $81.00K | -82.4% |
| Q3 FY2020 | Sep 30, 2020 | -$161.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $20.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $99.00K | -80.2% |
| Q4 FY2019 | Dec 31, 2019 | $459.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $500.00K | – |
See a number that looks wrong?